Indications and Purposes
| 1 Indications And Usage Symbicort Is A Combination Product Containing A Corticosteroid And A Long-Acting Beta 2 -Adrenergic Agonist Indicated For: • Treatment Of Asthma In Patients 6 Years Of Age And Older. ( 1.1 ) • Maintenance Treatment Of Airflow Obstruction And Reducing Exacerbations In Patients With Chronic Obstructive Pulmonary Disease (copd) Including Chronic Bronchitis And/or Emphysema. ( 1.2 ) Important Limitations: • Not Indicated For The Relief Of Acute Bronchospasm. ( 1.1 , 1.2 ) 1.1 Treatment Of Asthma Symbicort Is Indicated For The Treatment Of Asthma In Patients 6 Years Of Age And Older. Symbicort Should Be Used For Patients Not Adequately Controlled On A Long-Term Asthma-Control Medication Such As An Inhaled Corticosteroid (ics) Or Whose Disease Warrants Initiation Of Treatment With Both An Inhaled Corticosteroid And Long-Acting Beta2-Adrenergic Agonist (laba). Important Limitations Of Use: • Symbicort Is Not Indicated For The Relief Of Acute Bronchospasm. 1.2 Maintenance Treatment Of Chronic Obstructive Pulmonary Disease Symbicort 160/4.5 Is Indicated For The Maintenance Treatment Of Airflow Obstruction In Patients With Chronic Obstructive Pulmonary Disease (copd) Including Chronic Bronchitis And/or Emphysema. Symbicort 160/4.5 Is Also Indicated To Reduce Exacerbations Of Copd. Symbicort 160/4.5 Is The Only Strength Indicated For The Treatment Of Copd. Important Limitations Of Use: • Symbicort Is Not Indicated For The Relief Of Acute Bronchospasm. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Budesonide |
|
ZINC3938751 |
| 2. Formoterol Fumarate |
|
ZINC856 |